2 false false false false false false false false false false true false false false false false false No description of principal activity 2022-12-01 Sage Accounts Production Advanced 2023 - FRS102_2023 xbrli:pure xbrli:shares iso4217:GBP 06608574 2022-12-01 2023-11-30 06608574 2023-11-30 06608574 2022-11-30 06608574 2021-12-01 2022-11-30 06608574 2022-11-30 06608574 2021-11-30 06608574 core:PlantMachinery 2022-12-01 2023-11-30 06608574 core:FurnitureFittings 2022-12-01 2023-11-30 06608574 bus:LeadAgentIfApplicable 2022-12-01 2023-11-30 06608574 bus:Director1 2022-12-01 2023-11-30 06608574 core:WithinOneYear 2023-11-30 06608574 core:WithinOneYear 2022-11-30 06608574 core:AfterOneYear 2023-11-30 06608574 core:AfterOneYear 2022-11-30 06608574 core:ShareCapital 2023-11-30 06608574 core:ShareCapital 2022-11-30 06608574 core:RetainedEarningsAccumulatedLosses 2023-11-30 06608574 core:RetainedEarningsAccumulatedLosses 2022-11-30 06608574 bus:SmallEntities 2022-12-01 2023-11-30 06608574 bus:AuditExemptWithAccountantsReport 2022-12-01 2023-11-30 06608574 bus:SmallCompaniesRegimeForAccounts 2022-12-01 2023-11-30 06608574 bus:PrivateLimitedCompanyLtd 2022-12-01 2023-11-30 06608574 bus:AbridgedAccounts 2022-12-01 2023-11-30 06608574 core:ComputerEquipment 2022-12-01 2023-11-30
STATEMENT OF CONSENT TO PREPARE ABRIDGED FINANCIAL STATEMENTS
All of the members of @ Serenity The Beauty Clinic (UK) Limited have consented to the preparation of the abridged statement of income and retained earnings and the abridged statement of financial position for the year ending 30 November 2023 in accordance with Section 444(2A) of the Companies Act 2006.
COMPANY REGISTRATION NUMBER: 06608574
@ SERENITY THE BEAUTY CLINIC (UK) LIMITED
FILLETED UNAUDITED ABRIDGED FINANCIAL STATEMENTS
FOR THE YEAR ENDED
30 November 2023
@ SERENITY THE BEAUTY CLINIC (UK) LIMITED
REPORT TO THE DIRECTOR ON THE PREPARATION OF THE UNAUDITED STATUTORY ABRIDGED FINANCIAL STATEMENTS OF @ SERENITY THE BEAUTY CLINIC (UK) LIMITED
YEAR ENDED 30 NOVEMBER 2023
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the abridged financial statements of @ Serenity The Beauty Clinic (UK) Limited for the year ended 30 November 2023, which comprise the abridged statement of financial position and the related notes from the company's accounting records and from information and explanations you have given us. As a practising member firm of the Association of Chartered Certified Accountants, we are subject to its ethical and other professional requirements which are detailed at www.accaglobal.com/en/member/professional-standards/rules-standards/acca-rulebook.html. Our work has been undertaken in accordance with the requirements of the Association of Chartered Certified Accountants as detailed at www.accaglobal.com/content/dam/ACCA_Global/Technical/fact/technical-factsheet-163.pdf.
LANGARD LIFFORD HALL LIMITED Accountants and Registered Auditors
Lifford Hall Lifford Lane Kings Norton Birmingham B30 3JN
8 April 2024
@ SERENITY THE BEAUTY CLINIC (UK) LIMITED
ABRIDGED STATEMENT OF FINANCIAL POSITION
30 November 2023
2023
2022
Note
£
£
£
£
Fixed Assets
Tangible assets
5
89,126
111,404
Current Assets
Stocks
3,277
2,750
Debtors
2,734
Cash at bank and in hand
36,128
28,513
------------
------------
39,405
33,997
Creditors: amounts falling due within one year
31,446
12,888
------------
------------
Net Current Assets
7,959
21,109
------------
------------
Total Assets Less Current Liabilities
97,085
132,513
Creditors: amounts falling due after more than one year
16,514
25,857
------------
------------
Net Assets
80,571
106,656
------------
------------
Capital and Reserves
Called up share capital
100
100
Profit and loss account
80,471
106,556
------------
------------
Shareholder Funds
80,571
106,656
------------
------------
These abridged financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the abridged statement of income and retained earnings has not been delivered.
For the year ending 30 November 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The member has not required the company to obtain an audit of its abridged financial statements for the year in question in accordance with section 476 ;
- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of abridged financial statements .
@ SERENITY THE BEAUTY CLINIC (UK) LIMITED
ABRIDGED STATEMENT OF FINANCIAL POSITION (continued)
30 November 2023
These abridged financial statements were approved by the board of directors and authorised for issue on 8 April 2024 , and are signed on behalf of the board by:
K Sidhu
Director
Company registration number: 06608574
@ SERENITY THE BEAUTY CLINIC (UK) LIMITED
NOTES TO THE ABRIDGED FINANCIAL STATEMENTS
YEAR ENDED 30 NOVEMBER 2023
1. General Information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Lifford Hall, Lifford Lane, Kings Norton, Birmingham, West Midlands, B30 3JN, England.
2. Statement of Compliance
These abridged financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting Policies
Basis of preparation
The abridged financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The abridged financial statements are prepared in sterling, which is the functional currency of the entity.
Judgements and key sources of estimation uncertainty
The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported. These estimates and judgements are continually reviewed and are based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax. Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.
Tangible assets
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in equity, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation, is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in equity in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in equity in respect of that asset, the excess shall be recognised in profit or loss.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
Plant and machinery
-
20% straight line
Fixtures and fittings
-
20% straight line
Equipment
-
20% straight line
Impairment of fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets. For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units.
Stocks
Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost includes all costs of purchase, costs of conversion and other costs incurred in bringing the stock to its present location and condition.
Financial instruments
Financial instruments are classified and accounted for, according to the substance of the contractual arrangement, as either financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.
4. Employee Numbers
The average number of persons employed by the company during the year amounted to 2 (2022: 2 ).
5. Tangible Assets
£
Cost
At 1 December 2022 and 30 November 2023
111,404
------------
Depreciation
At 1 December 2022
Charge for the year
22,278
------------
At 30 November 2023
22,278
------------
Carrying amount
At 30 November 2023
89,126
------------
At 30 November 2022
111,404
------------
6. Director's Advances, Credits and Guarantees
Amounts owed to the director at the balance sheet date are included in creditors and totalled £9,582 (2022: £nil).